Carbonix Therapeutics

Precision antibiotics for an innovative approach to treating infection and microbiome related diseases.

A new approach to infectious disease, and the downstream consequences of microbiome dysbiosis.

Technology

A precision mechanism that conventional antibiotics cannot exploit

Carbonix is a small-molecule antibiotic company that targets a biological pathway uniquely essential to Enterococcus species.

Learn more
Microbiome

Treating infection without destroying the ecosystem within

Broad-spectrum antibiotics indiscriminately destroy commensal gut flora, driving dysbiosis linked to secondary infections, impaired immune recovery, and emerging autoimmune and neurological disorders. Our narrow-spectrum approach preserves microbiome diversity through treatment.

Learn more